Research progress of circular RNAs in myocardial ischemia
Life Sciences · 2024
DOI: 10.1016/j.lfs.2024.122809 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Life Sciences, 2024. Verfasst von Jonnea Japhet Tibenda und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Key Laboratory of Hui Ethnic Medicine Modernization, Ministry of Education, Ningxia Medical University, Ningxia, China. Hauptthemen laut MEDLINE: RNA, Circular, Myocardial Ischemia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 175 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Circular RNAs (circRNAs) are a type of single-stranded RNA that forms a covalently closed continuous loop. Its structure, stability, properties, and cell- and tissue-specificity have gained considerable recognition in the research and clinical sectors, as its role has been observed in different diseases, such as cardiovascular diseases, cancers, and central nervous system diseases, etc. Cardiovascular disease is still named as the number one cause of death globally, with myocardial ischemia (MI) accounting for 15 % of mortality annually. A number of circRNAs have been identified and are being studied for their ability to reduce MI by inhibiting the molecular mechanisms associated with myocardial ischemia reperfusion injury, such as inflammation, oxidative stress, autophagy, apoptosis, and so on. CircRNAs play a significant role as crucial regulatory elements at transcriptional levels, regulating different proteins, and at posttranscriptional levels, having interactions with RNA-binding proteins, ribosomal proteins, micro-RNAS, and long non-coding RNAS, making it possible to exert their effects through the circRNA-miRNA-mRNA axis. CircRNAs are a potential novel biomarker and therapeutic target for myocardial ischemia and cardiovascular diseases in general. The purpose of this review is to summarize the relationship, function, and mechanism observed between circRNAs and MI injury, as well as to provide directions for future research and clinical trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Key Laboratory of Hui Ethnic Medicine Modernization, Ministry of Education, Ningxia Medical University, Ningxia, China.
- Innovative Institute of Chinese Medicine and Pharmacy/Academy for Interdiscipline, Chengdu University of Traditional Chinese Medicine, Chengdu, China. Electronic address: VitaDrwang@cdutcm.edu.cn.
- Department of Cardiology, General Hospital of Ningxia Medical University, Ningxia, China. Electronic address: zhangzhengjun-0@nxmu.edu.cn.
- School of Pharmacy, Key Laboratory of Hui Ethnic Medicine Modernization, Ministry of Education, Ningxia Medical University, Ningxia, China. Electronic address: zhqp623@nxmu.edu.cn.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Tibenda, J. J., Wang, N., Li, N., Dang, Y., Zhu, Y., Wang, X., Zhang, Z., & Zhao, Q. (2024). Research progress of circular RNAs in myocardial ischemia. Life Sciences. https://doi.org/10.1016/j.lfs.2024.122809
Vancouver
Tibenda JJ, Wang N, Li N, Dang Y, Zhu Y, Wang X, et al. Research progress of circular RNAs in myocardial ischemia. Life Sciences. 2024. doi:10.1016/j.lfs.2024.122809
BibTeX
@article{Tibenda2024,
author = {Tibenda, Jonnea Japhet and Wang, Niuniu and Li, Nuan and Dang, Yanning and Zhu, Yafei and Wang, Xiaobo and Zhang, Zhengjun and Zhao, Qipeng},
title = {Research progress of circular RNAs in myocardial ischemia},
journal = {Life Sciences},
year = {2024},
doi = {10.1016/j.lfs.2024.122809}
}
EUVIMED